Vendor, Bellefonte, PA
Actuated Medical, Inc.
UEI VG84D4KN5LR5, CAGE 4NZ54
6 awards and $139,320 obligated between November 22, 2024 and July 15, 2026, 100% under full and open competition, against 2.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $139,320 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 6 |
| Delivery Order | 5 |
Hear when Actuated Medical, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Actuated Medical, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 3
- Obligated so far
- $131,392
- Soonest
- December 31, 2026
The 3 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,453,292 |
| Westat, Inc.Rockville, MD | $762,955,645 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95025F00004Delivery Order, August 14, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Endovascular Horizons Testing TO5. Research and Development for Biocompatibility Testing, Animal Studies, and Sterilization Testing in the BNAICS 541715, PSC AN11 | $65,696 |
| 75N95025F00003Delivery Order, July 10, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Task Order 04: Biocompatibility Testing for Rhaeos. Period of Performance: 7/14/2025 - 1/13/2026NAICS 541715, PSC AN11 | $32,848 |
| 75N95025F00005Delivery Order, August 14, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Biocompatibility Testing for Neurastasis. Research and Development for Biocompatibility Testing, Animal Studies, and Sterilization Testing iNAICS 541715, PSC AN11 | $32,848 |
| 75N95025F00001Delivery Order, November 22, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Research and Development for Biocompatibility Testing, Animal Studies, and Sterilization Testing in the Blueprint Medtech (Bpmt) Initiative NAICS 541715, PSC AN11 | $8,010 |
| 75N95023D00022December 16, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | Research and Development for Biocompatibility Testing, Animal Studies, and Sterilization Testing in the Blueprint Medtech (Bpmt) InitiativeNAICS 541715, PSC AN11 | $0 |
| 75N95023F00001Delivery Order, June 4, 2026, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative. Research and Development for Biocompatibility Testing, Animal Studies, and Sterilization Testing in the Blueprint MedteNAICS 541715, PSC AN11 | -$82 |
- Places of performance
- Pennsylvania
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 10 across 6 awards